aTyr Pharma, Inc.
ATYR
$5.35
$0.408.08%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -66.64M | -63.41M | -64.02M | -63.82M | -57.90M |
| Total Depreciation and Amortization | 1.16M | 1.15M | 1.54M | 1.95M | 2.55M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.86M | 1.00M | 282.00K | -162.00K | -618.00K |
| Change in Net Operating Assets | 8.02M | -903.00K | -6.92M | -5.02M | -7.49M |
| Cash from Operations | -55.60M | -62.16M | -69.12M | -67.05M | -63.45M |
| Capital Expenditure | -49.00K | -48.00K | -65.00K | -57.00K | -599.00K |
| Sale of Property, Plant, and Equipment | 7.00K | 7.00K | 7.00K | 0.00 | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 10.78M | 14.21M | 17.29M | 41.19M | 28.17M |
| Cash from Investing | 10.74M | 14.17M | 17.23M | 41.14M | 27.57M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -517.00K | -507.00K | -497.00K | -484.00K | -467.00K |
| Issuance of Common Stock | 55.78M | 51.27M | 40.36M | 27.54M | 30.31M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 55.26M | 50.76M | 39.86M | 27.06M | 29.85M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.40M | 2.77M | -12.02M | 1.15M | -6.03M |